Terms: = Pancreatic cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
89 results:
1. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking jak2/STAT3 signaling.
Xie S; Li X; Yan J; Yu H; Chen S; Chen K
Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
[TBL] [Abstract] [Full Text] [Related]
2. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the jak2/STAT3 pathway.
Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
[TBL] [Abstract] [Full Text] [Related]
3. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
4. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
Goad DW; Nesmelova AY; Yohe LR; Grdzelishvili VZ
J Virol; 2023 Sep; 97(9):e0100523. PubMed ID: 37671865
[TBL] [Abstract] [Full Text] [Related]
5. Phosphorylation of PPDPF via IL6-jak2 activates the Wnt/β-catenin pathway in colorectal cancer.
Zi Y; Liu L; Gao J; Xu X; Guan Y; Rong Z; Cao Z; Li M; Zeng Z; Fan Q; Tang F; He J; Feng D; Chen J; Dai Y; Huang Y; Nie Y; Pei H; Cai Q; Li Z; Sun L; Deng Y
EMBO Rep; 2023 Sep; 24(9):e55060. PubMed ID: 37477088
[TBL] [Abstract] [Full Text] [Related]
6. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-jak2-STAT3 axis.
Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
[TBL] [Abstract] [Full Text] [Related]
7. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
[TBL] [Abstract] [Full Text] [Related]
8. Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of pancreatic Ductal Adenocarcinoma.
Kong Y; Luo Y; Zheng S; Yang J; Zhang D; Zhao Y; Zheng H; An M; Lin Y; Ai L; Diao X; Lin Q; Chen C; Chen R
Cancer Res; 2023 Sep; 83(18):3077-3094. PubMed ID: 37363990
[TBL] [Abstract] [Full Text] [Related]
9. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
[TBL] [Abstract] [Full Text] [Related]
10. The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.
Entrialgo-Cadierno R; Cueto-Ureña C; Welch C; Feliu I; Macaya I; Vera L; Morales X; Michelina SV; Scaparone P; Lopez I; Darbo E; Erice O; Vallejo A; Moreno H; Goñi-Salaverri A; Lara-Astiaso D; Halberg N; Cortes-Dominguez I; Guruceaga E; Ambrogio C; Lecanda F; Vicent S
Mol Cancer; 2023 May; 22(1):86. PubMed ID: 37210549
[TBL] [Abstract] [Full Text] [Related]
11. STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
Al-Hetty HRAK; Abdulameer SJ; Alkubaisy SA; Zaid SA; Jalil AT; Jasim IK
Pathol Res Pract; 2023 May; 245():154425. PubMed ID: 37019018
[TBL] [Abstract] [Full Text] [Related]
12. Mebendazole Impedes the Proliferation and Migration of pancreatic cancer Cells through SK1 Inhibition Dependent Pathway.
Limbu KR; Chhetri RB; Oh YS; Baek DJ; Park EY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500220
[TBL] [Abstract] [Full Text] [Related]
13. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma.
Sun X; Chu H; Lei K; Ci Y; Lu H; Wang J; Zhou M; Ren H; Zheng T
Pancreatology; 2022 Sep; 22(6):749-759. PubMed ID: 35717305
[TBL] [Abstract] [Full Text] [Related]
14. MUC16 Promotes Liver Metastasis of pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion.
Marimuthu S; Lakshmanan I; Muniyan S; Gautam SK; Nimmakayala RK; Rauth S; Atri P; Shah A; Bhyravbhatla N; Mallya K; Grandgenett PM; Hollingsworth MA; Datta K; Jain M; Ponnusamy MP; Batra SK
Mol Cancer Res; 2022 Aug; 20(8):1208-1221. PubMed ID: 35533267
[TBL] [Abstract] [Full Text] [Related]
15. PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in pancreatic cancer.
Wang Y; Zheng K; Xiong H; Huang Y; Chen X; Zhou Y; Qin W; Su J; Chen R; Qiu H; Yuan X; Wang Y; Zou Y
Front Immunol; 2021; 12():762989. PubMed ID: 34975854
[TBL] [Abstract] [Full Text] [Related]
16. Serum JAK/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients.
Petrusel L; Ilies M; Leucuta D; Rusu I; Seicean A; Iuga C; Seicean R
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):107-112. PubMed ID: 34933726
[TBL] [Abstract] [Full Text] [Related]
17. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling.
Xiao Y; Liu Y; Gao Z; Li X; Weng M; Shi C; Wang C; Sun L
Aging (Albany NY); 2021 Nov; 13(22):24753-24767. PubMed ID: 34821587
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of jak2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
Fan X; Fu H; Xie N; Guo H; Fu T; Shan Y
Aging (Albany NY); 2021 Oct; 13(19):22830-22842. PubMed ID: 34623971
[TBL] [Abstract] [Full Text] [Related]
19. Tumour-Derived Reg3A Educates Dendritic Cells to Promote pancreatic cancer Progression.
Guo J; Liao M; Hu X; Wang J
Mol Cells; 2021 Sep; 44(9):647-657. PubMed ID: 34504050
[TBL] [Abstract] [Full Text] [Related]
20. Targeting HDACs in pancreatic Neuroendocrine Tumor Models.
Schmitz RL; Weissbach J; Kleilein J; Bell J; Hüttelmaier S; Viol F; Clauditz T; Grabowski P; Laumen H; Rosendahl J; Michl P; Schrader J; Krug S
Cells; 2021 Jun; 10(6):. PubMed ID: 34204116
[TBL] [Abstract] [Full Text] [Related]
[Next]
